An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 302 participants.

Also called NCT02082184

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 302 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02082184
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
France, Germany, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02082184. Randomized; no masking; primary purpose other. Start 2014-03 (registry gives no type); primary completion 2015-06 (actual). Results posted on 2017-04-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes
Acronym
REPLACE
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Sensor Based Glucose Monitoring System
Intervention (Device)
Standard Blood Glucose Monitoring
Lead sponsor
Abbott Diabetes Care (class: industry)

Record details

Record id
cardio:ct-nct02082184
Content hash
b3dccb8f214d2145d296cbc95caf58b92e7eb9b35e376c3227a2760cc7787a5c